• Home
  • The MMS Difference
    • About Us
    • Leadership
    • Certifications
  • Services
    • Regulatory Affairs and Operations
    • Data Management and Biostatistics
    • Regulatory and Medical Writing
    • Drug Safety and Pharmacovigilance
    • Compliance and Transparency
    • Data Sciences
  • Working with MMS
  • News and Media
  • Webinars
  • MMS Blog
  • Careers
  • Contact Us
MMS
Why Should GDPR Matter to all Clinical Research Firms?

Why Should GDPR Matter to all Clinical Research Firms?

by curtis@digitalliance.com | May 24, 2018 | Blog

Why Should GDPR Matter to all Clinical Research Firms? by Barbara Rusin Since the beginning of 2018, there has been a growing interest from pharmaceutical and biotech firms in the United States regarding the basic tenets of the European Union’s (EU) new General Data...

Recent Posts

  • Why COVID-19 testing devices require a high level of specificity
  • Whitepaper: Pharmaceutical Industry Challenges Facing Clinical Trial Disclosure and Transparency
  • Helping to Accelerate the Search for Solutions to the COVID-19 Crisis
  • IGY Life Sciences Partners with MMS Holdings to Develop Novel COVID-19 Antibody Treatment
  • Pharmaceutical Industry News Roundup: May 2020

Tags

ALZ awareness Alzheimers big data biosimilars biostatistics Clinical Development clinical research clinical study reports clinical trials clinical trial transparency Community Compliance COVID-19 CRO data management data privacy data science drug development EMA ENDALZ FDA Flint GDPR GXP auditing Health Analytics Collective Health Canada Lay summaries leadership medical writing NDA submission opioids pharma pharmacovigilance PhUSE Policy 0070 quality control real world data regulatory operations REMS resourcing statistical programming suicidality transparency trial regulation Volunteering